Stay updated on Belapectin for Esophageal Varices in NASH Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Belapectin for Esophageal Varices in NASH Cirrhosis Clinical Trial page.

Latest updates to the Belapectin for Esophageal Varices in NASH Cirrhosis Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 to the history. Removed the operating-status notice related to government funding and the older Revision: v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide funding notice and a new revision label (v3.4.1), replacing the prior v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary toggle and color-coded change highlights (green for additions, red for deletions) in the history view, and updated the revision to v3.4.0 with the new 'No FEAR Act Data' text.SummaryDifference0.5%

- Check42 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer.SummaryDifference0.1%

- Check71 days agoChange DetectedThe history now notes that Stage 1 NAVIGATE was analyzed as a stand-alone trial per FDA feedback, and the record indicates a termination on 2025-12-15. It also updates core sections such as Contacts/Locations, Oversight, Study Status, and Recruitment Status to reflect the new information.SummaryDifference0.4%

Stay in the know with updates to Belapectin for Esophageal Varices in NASH Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belapectin for Esophageal Varices in NASH Cirrhosis Clinical Trial page.